Disease Attributes D020969

Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Disease Attributes

Description

Clinical characteristics of disease or illness.   MeSH

Hierarchy View

Subtype Terms (23)

Acute Disease
8 drugs (7 approved, 1 experimental)

Ambulatory Care Sensitive Conditions
 

Asymptomatic Diseases
8 drugs (5 approved, 3 experimental)

Breakthrough Infections
 

Catastrophic Illness
 

Chronic Disease
61 drugs (47 approved, 14 experimental)

Communicable Diseases
82 drugs (51 approved, 31 experimental)

Convalescence
1 experimental drug

Critical Illness
175 drugs (129 approved, 46 experimental)

Disease Progression
27 drugs (25 approved, 2 experimental)

Disease Resistance
2 approved drugs

Diseases in Twins
 

Disease Susceptibility
1 approved drug

Emergencies
20 approved drugs

Facies
1 experimental drug

Iatrogenic Disease
 

Late Onset Disorders
1 approved drug

Neglected Diseases
 

Noncommunicable Diseases
 

Persistent Infection
12 drugs (7 approved, 5 experimental)

Rare Diseases
11 drugs (9 approved, 2 experimental)

Recurrence
121 drugs (88 approved, 33 experimental)

Undiagnosed Diseases
 


Phase 2 Indicated Drugs (1)

Other Experimental Indicated Drugs (2)


Organization Involved with Other Experimental Indications (2)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.